References in periodicals archive ?
Adalat CC is indicated for the treatment of hypertension and is marketed by Bayer Corporation.
C) BAYER agreed to settle its civil liabilities to forty-nine states and the District of Columbia in an amount of $108,956,961, plus applicable interest, in civil damages for losses suffered by the state funded portion of the Medicaid program as a result of BAYER's failure to report the price of private label Cipro, and later Adalat CC, as its best price for those drugs.
Biovail, through its marketing partner Teva Pharmaceuticals, is currently marketing generic versions of Adalat CC (30mg and 60mg) and Procardia XL (60mg) dosage strengths.
Eugene Melnyk, Chairman of the Board, commented, "Biovail's 70% increase in total revenues is primarily due to the launch of several new products including generic versions of Voltaren XR and Adalat CC 30 mg and the first commercial launch of a product utilizing Biovail's flash dose technology.
equivalent to Adalat CC (a sustained release form of nifedipine
Biovail Corporation (NYSE:BVF)(TSE:BVF) today announced that its in-licensed 30mg dosage strength of generic Adalat CC (once daily nifedipine) has been granted final approval by the Food and Drug Administration (FDA) for immediate marketing in the United States.
NOTE TO EDITORS: Prescribing information for BAYCOL -- 18 pages, Adalat, Adalat CC, and Trasylol is available via fax-on-demand by calling 800-753-0352, ext.
See accompanying prescribing information for Adalat CC.
Current annual sales of Adalat CC are estimated at $357 million.
Cipro, cardiovascular products such as Adalat CC, and advanced
The five currently marketed products include morphine sulfate extended release capsules, the generic version of Kadian, fentanyl transdermal system CII, the generic equivalent of Duragesic, nifedipine extended release tablets, the generic version of Adalat CC, diltiazem hydrochloride extended release capsules, the generic equivalent of Cardizem CD, and metoclopramide hydrochloride tablets, the generic version of Reglan.
Biovail Corporation (NYSE:BVF) (TSX:BVF) today announced that final approval by the Food and Drug Administration (FDA) has been granted for its 90 mg dosage strength of generic Adalat CC (once daily nifedipine).
May 30, 2012 /PRNewswire/ -- Actavis Group, an international generic pharmaceuticals company, today announced that it received US FDA approval of Nifedipine Extended-Release Tablets, USP, 90mg, a generic equivalent to Bayer's Adalat CC.